Matthew Snider, | |
9040 Fitzsimmons Dr, Joint Base Lewis Mcchord, WA 98431-1000 | |
(253) 968-0375 | |
Not Available |
Full Name | Matthew Snider |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 9040 Fitzsimmons Dr, Joint Base Lewis Mcchord, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740640960 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 01079780A (Indiana) | Secondary |
207W00000X | Ophthalmology | A185178 (California) | Primary |
Entity Name | Alaska Native Tribal Health Consortium |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for reduction in hyperactivity in mice treated with amphetamines. The mouse model screening was performed by the contract research organization, Cerca Insights.
Johns Hopkins researchers say they have confirmed suspicions that DNA modifications found in the blood of mice exposed to high levels of stress hormone — and showing signs of anxiety — are directly related to changes found in their brain tissues.
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease.
A Michigan State University study is the first to show an association between unusually high pesticide exposure and poor sense of smell among aging farmers.
UCLA researchers have discovered the inner workings of a gene network that regulates the development of spinal motor neurons in the growing chicken and mouse embryo.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Snider, 9040 Jackson Ave, Tacoma, WA 98431-0001 Ph: (708) 212-0884 | Matthew Snider, 9040 Fitzsimmons Dr, Joint Base Lewis Mcchord, WA 98431-1000 Ph: (253) 968-0375 |
News Archive
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for reduction in hyperactivity in mice treated with amphetamines. The mouse model screening was performed by the contract research organization, Cerca Insights.
Johns Hopkins researchers say they have confirmed suspicions that DNA modifications found in the blood of mice exposed to high levels of stress hormone — and showing signs of anxiety — are directly related to changes found in their brain tissues.
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease.
A Michigan State University study is the first to show an association between unusually high pesticide exposure and poor sense of smell among aging farmers.
UCLA researchers have discovered the inner workings of a gene network that regulates the development of spinal motor neurons in the growing chicken and mouse embryo.
› Verified 4 days ago
Natalie Husa, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9040 Fitzsimmons Dr, Joint Base Lewis Mcchord, WA 98431 Phone: 253-968-0369 | |
Dr. James Bailey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9040 A Jackson Ave, Joint Base Lewis Mcchord, WA 98431 Phone: 253-241-6725 |